細胞治療技術の市場規模、シェア、成長分析、タイプ別、プロセス別、細胞タイプ別、エンドユーザー別、地域別 - 産業予測、2024～2031年

細胞治療技術の世界市場規模は、2022年に39億米ドルと評価され、2023年の44億3,000万米ドルから2031年には121億9,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは13.50％で成長する見通しです。

細胞治療市場は、臨床研究への資金提供の増加と実用的な生産ガイドラインの確立に後押しされ、大きな成長を遂げています。質の高い研究が治療細胞開発の進展を促し、顕著な市場シェア拡大をもたらしています。臨床試験の増加は民間と政府の資金提供機関によって大きく支えられており、欧州のプロジェクトはEUの助成金によって頻繁に支援されています。例えば、Achilles Therapeutics は個別化医療をさらに進めるため、2022年7月に420万米ドルのHorizon Europe賞を獲得しました。さらに、CRISPR/Cas9のような遺伝子編集技術や製造の自動化など、細胞治療技術の進歩が細胞治療の拡張性と質を高めています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• 特許分析
• ケーススタディ

細胞治療技術市場規模：製品別およびCAGR（2024～2031年）

• 市場概要
• 培地血清試薬
• 細胞工学製品
• 細胞培養容器
• 細胞治療装置
  • 細胞処理装置
  • 使い捨て機器
  • その他の装備
• システムとソフトウェア
• その他の製品

細胞治療技術市場規模：プロセス別およびCAGR（2024～2031年）

• 市場概要
• 細胞処理
• 細胞の保存、分配、および取り扱い
• プロセス監視と品質管理

細胞治療技術市場規模：細胞タイプ別およびCAGR（2024～2031年）

• 市場概要
• T細胞
• 幹細胞
• その他の細胞

細胞治療技術市場規模：エンドユーザー別およびCAGR（2024～2031年）

• 市場概要
• バイオ医薬品およびバイオテクノロジー企業
• CROとCMO
• 調査機関と細胞バンク

細胞治療技術市場規模およびCAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Danaher Corporation
• Lonza Group
• Sartorius AG
• Terumo BCT, Inc.
• Becton Dickinson and Company
• Fresenius SE & Co. KGaA
• Avantor, Inc.
• Bio-Techne
• Corning Incorporated
• Fujifilm Irvine Scientific
• MaxCyte, Inc.
• Werum IT Solutions
• RoosterBio, Inc.
• TrakCel
• L7 Informatics, Inc.
• Miltenyi Biotec B.V. & Co. KG
• STEMCELL Technologies
• GPI Iberia（formerly Hemasoft）

結論と推奨事項

Global Cell Therapy Technologies Market size was valued at USD 3.9 billion in 2022 and is poised to grow from USD 4.43 billion in 2023 to USD 12.19 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).

The cell therapy market is experiencing significant growth fueled by increased funding for clinical research and the establishment of practical guidelines for production. Robust quality research is driving the advancement of therapeutic cell development, resulting in a notable market share expansion. The rise in clinical trials is largely supported by both private and government funding agencies, with European projects frequently backed by EU grants; for instance, Achilles Therapeutics secured a $4.2 million Horizon Europe award in July 2022 to further personalized medicine. Additionally, advancements in cell therapy techniques, including gene editing technologies like CRISPR/Cas9 and automation in manufacturing, are enhancing the scalability and quality of cell therapies, while regulatory approvals remain a decisive factor in market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Therapy Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Therapy Technologies Market Segmental Analysis

Global Cell Therapy Technologies Market is segmented by Type, Process, Cell Type, End User, and region. Based on Type, the market is segmented into Media, sera, and reagents, Cell engineering products, Cell culture vessels, Cell therapy equipment, Systems & software, and Other products. Based on Process, the market is segmented into Cell Processing, Cell preservation, distribution, and handling, and Process monitoring & quality control. Based on Cell Type, the market is segmented into T cells, Stem cells, and Other cells. Based on End User, the market is segmented into Biopharmaceutical & biotechnology companies, CROs & CMOs, and Research institutes & cell banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Therapy Technologies Market

One of the key drivers fueling the expansion of the global cell therapy technologies market is the continuous emergence of innovative therapies. This growth is largely attributable to the frequent introduction of advanced technologies aimed at facilitating state-of-the-art treatments. Notably, the deployment of proprietary cell lines is recognized as an effective method for achieving a substantial target population for specific products. A prime example of this is Immunicum's utilization of Chimeric Antigen Receptor T cell (CAR-T) expansion, along with dendritic cell neoantigen presentation techniques and T-cell priming strategies, all of which significantly enhance the development of their immuno-oncology portfolio.

Restraints in the Global Cell Therapy Technologies Market

The Global Cell Therapy Technologies market faces significant challenges due to a shortage of skilled labor. Despite notable technological progress and innovations in recent years, there remains a dearth of qualified personnel capable of operating sophisticated instruments like flow cytometers and spectrophotometers. These advanced tools produce substantial volumes of data, necessitating a high level of expertise for effective analysis and interpretation. This gap in skilled workforce not only hampers operational efficiency but also poses a barrier to the overall growth and advancement of the cell therapy sector, potentially limiting its ability to leverage technological advancements fully.

Market Trends of the Global Cell Therapy Technologies Market

The Global Cell Therapy Technologies market is experiencing significant growth, driven by the increasing demand for advanced analytical tools that enhance quality control and improvement. Innovative diagnostics, imaging technologies, and robust data analytics facilitate the streamlined monitoring and characterization of cellular materials, ensuring enhanced efficacy and safety profiles. The development of new biomaterials and scaffolds for improved cell delivery and engraftment is garnering heightened interest, offering benefits like better biocompatibility and controlled release kinetics. Moreover, intensified collaboration between research institutions is fostering innovation, aiding the rapid translation of cell therapy technologies from laboratory research to clinical application, positioning this sector for continued expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Cell Therapy Technologies Market Size by Product & CAGR (2024-2031)

• Market Overview
• Media, sera, and reagents
• Cell engineering products
• Cell culture vessels
• Cell therapy equipment
  • Cell Processing equipment
  • Single-use equipment
  • Other equipment
• Systems & software
• Other products

Global Cell Therapy Technologies Market Size by Process & CAGR (2024-2031)

• Market Overview
• Cell Processing
• Cell preservation, distribution, and handling
• Process monitoring & quality control

Global Cell Therapy Technologies Market Size by Cell Type & CAGR (2024-2031)

• Market Overview
• T cells
• Stem cells
• Other cells

Global Cell Therapy Technologies Market Size by End User & CAGR (2024-2031)

• Market Overview
• Biopharmaceutical & biotechnology companies
• CROs & CMOs
• Research institutes & cell banks

Global Cell Therapy Technologies Market Size & CAGR (2024-2031)

• North America (Product, Process, Cell Type, End User)
  • US
  • Canada
• Europe (Product, Process, Cell Type, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Process, Cell Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Process, Cell Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Process, Cell Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Irvine Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MaxCyte, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werum IT Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RoosterBio, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TrakCel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• L7 Informatics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec B.V. & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GPI Iberia (formerly Hemasoft)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation